Weesp, Netherlands

Jules A C Elbers

This inventor holds 1 USPTO granted patent. Top assignee: Duphar International Research Bv. Active years: 2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jules A C Elbers. Retrieved from https://idiyas.com/inventor/jules-a-c-elbers

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 18(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jules A C Elbers: Innovator in Oral Formulations

Introduction

Jules A C Elbers is a notable inventor based in Weesp, Netherlands. He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of oral delayed immediate release formulations. His innovative work has led to the granting of a patent that showcases his expertise and dedication to advancing medical science.

Latest Patents

Jules A C Elbers holds a patent for an "Oral delayed immediate release formulation and method for preparing the same." This patent highlights his ability to create effective solutions for drug delivery, which is crucial in enhancing patient outcomes.

Career Highlights

Elbers is associated with Duphar International Research Bv, where he applies his knowledge and skills to further research and development in the pharmaceutical industry. His work at Duphar has positioned him as a key player in the field of drug formulation.

Collaborations

Throughout his career, Jules has collaborated with esteemed colleagues such as Paulus M Van Balken and Henderik W Frijlink. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Jules A C Elbers is a distinguished inventor whose contributions to oral formulations have made a significant impact in the pharmaceutical industry. His patent and collaborative efforts reflect his commitment to advancing medical science and improving drug delivery methods.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…